Company / Financials
Arcadia Biosciences, Inc. Financials
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$5.0M
FY2025 · +13.3% YoY
Net Income
-$7.0M
FY2025 · +49.7% YoY
Profit Margin
-139.5%
FY2025 · net income / revenue
ROE
-113.1%
FY2025 · return on equity
Total Assets
$6.5M
FY2025
Total Debt
-
FY2025
Equity
$6.2M
FY2025
ROA
-107.5%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 7.60 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$5.0M+13.3% YoYNet Income HistoryProfit after all expenses and taxes-$7.0M+49.7% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$3.0M+36.3% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$3.6M+40.2% YoYSG&A Expense HistorySelling, general, and administrative expenses$9.6M+17.1% YoYR&D Expense HistoryResearch and development spending$53.0K-17.2% YoYInterest Expense HistoryCost of borrowing and debt obligations$782.0K+12.5% YoYIncome Tax HistoryTotal income tax expense$8.0K0.0% YoYEPS (Basic) HistoryBasic earnings per share-$5.17+54.2% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles-$5.17+54.2% YoY